Diabetes and high blood pressure claims surge among younger adults, highlighting urgent health concerns
EVP at Beneva on how biosimilars plays a key role in their cost savings strategy
Wegovy becomes Canada's first dual therapy for weight and heart attack risk management
Comprehensive updates offer evidence-based strategies for managing migraines in Canadian patients
New data reveals a surge in demand for obesity, diabetes, and mental health medications in Canada
Projected 7.4% rise in Canada’s medical costs shifts focus to chronic conditions and efficiency
